Levomilnacipran and Dissociation - a phase IV clinical study of FDA data

Summary:

Dissociation is reported as a side effect among people who take Levomilnacipran (levomilnacipran), especially for people who are male, 40-49 old, also take Clonazepam, and have Bipolar disorder.

The phase IV clinical study analyzes which people have Dissociation when taking Levomilnacipran. It is created by eHealthMe based on reports of 117 people who have side effects when taking Levomilnacipran from the FDA, and is updated regularly.

What is Levomilnacipran?

Levomilnacipran has active ingredients of levomilnacipran. eHealthMe is studying from 118 Levomilnacipran users. Check the latest studies of Levomilnacipran.

What is Dissociation?

Dissociation is found to be associated with 338 drugs and 536 conditions by eHealthMe. Check the latest studies of Dissociation.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Aug, 30, 2026

117 people reported to have side effects when taking Levomilnacipran.
Among them, 15 people (12.82%) have Dissociation.

Could Levomilnacipran cause Dissociation?

Among these 15 people:

What is the gender of people who have Dissociation when taking Levomilnacipran? *

female: 6.67 %
male: 93.33 %

What is the age of people who have Dissociation when taking Levomilnacipran? *

What are other drugs people take besides Levomilnacipran? *

What are other side effects people have besides Dissociation? *

Drug Ineffective: 12 people, 80.00%
Nausea (feeling of having an urge to vomit): 3 people, 20.00%
Dizziness: 3 people, 20.00%
Heart Attack: 2 people, 13.33%
Pneumonia: 2 people, 13.33%
Headache (pain in head): 1 person, 6.67%
Anger: 1 person, 6.67%
Balance Disorder: 1 person, 6.67%
Confusional State: 1 person, 6.67%
Disturbance In Attention: 1 person, 6.67%

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 12 people, 80.00%
Depression: 4 people, 26.67%
Major Depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings): 3 people, 20.00%
Mood Swings (an extreme or rapid change in mood): 2 people, 13.33%
Antiphospholipid Syndrome (disorder that manifests clinically as recurrent venous or arterial thrombosis and/or fetal loss): 2 people, 13.33%

* Approximation only. Some reports may have incomplete information.

Do you take Levomilnacipran and have Dissociation?

- Check whether Dissociation is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Levomilnacipran:

Levomilnacipran (118 reports)

Dissociation treatments and more:

Dissociation (5,922 reports)

Browse all side effects of Levomilnacipran:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Dissociation:

Dissociation (338 drugs)

Browse all the conditions that are associated with Dissociation:

Dissociation (536 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on levomilnacipran (the active ingredients of Levomilnacipran) and Levomilnacipran (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.